Clinical Trial Update: Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT) [Phase 2]

View source ↗

Summary

This Phase 2 trial assessing bevacizumab in combination with Visudyne photodynamic therapy for age-related macular degeneration and related neovascular conditio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization
• Macular Edema

Drugs mentioned

• Bevacizumab (bevacizumab)
• Visudyne (verteporfin)

Snippet

Sponsor: California Retina Consultants | Conditions: Age Related Macular Degeneration, Choroidal Neovascularization | Phase 2 | Status: COMPLETED | Results posted: 2016-04-20